KR20170133297A - Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell - Google Patents
Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell Download PDFInfo
- Publication number
- KR20170133297A KR20170133297A KR1020170157301A KR20170157301A KR20170133297A KR 20170133297 A KR20170133297 A KR 20170133297A KR 1020170157301 A KR1020170157301 A KR 1020170157301A KR 20170157301 A KR20170157301 A KR 20170157301A KR 20170133297 A KR20170133297 A KR 20170133297A
- Authority
- KR
- South Korea
- Prior art keywords
- cosmetic composition
- skin
- composition according
- extracellular matrix
- molecular weight
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 세포 외 기질을 모사하여 피부 세포의 재생을 돕는 화장료 조성물에 관한 것으로, 보다 상세하게는 효과적인 피부 투과를 위해 저분자 물질들로 이루어진 유효성분들을 세포 외 기질과 유사한 조성비로 함유하는 화장료 조성물에 관한 것이다. 본 발명의 화장료 조성물은 피부의 회복을 도와 항상성을 유지시키고 피부 세포의 재생에 효과적이다.The present invention relates to a cosmetic composition for stimulating the regeneration of skin cells by simulating an extracellular matrix, and more particularly, to a cosmetic composition containing an effective ingredient having a low molecular weight in a composition ratio similar to that of an extracellular matrix . The cosmetic composition of the present invention helps the skin to recover and maintain the homeostasis, and is effective for the regeneration of skin cells.
모든 생명체는 나이를 먹으면서 노화되며 피부에서도 마찬가지로 노화 과정을 거치게 된다. 이러한 노화를 지연하고자 하는 노력은 끊임없이 이어져 왔으며, 이에 따라 노화의 본질이 무엇이며 노화가 왜 일어나는지에 대한 의문은 끊임없이 제기되고 있다. 피부의 노화는 그 요인에 따라 크게 두 가지로 구분할 수 있다. 그 중 하나인 자연적인 노화(Intrinsic aging)는 피부의 구조와 생리적인 기능이 나이를 먹으면서 계속적인 감퇴를 일으키는 것이고, 다른 하나인 외적 노화(Extrinsic aging)는 태양광선 등 누적된 외부 스트레스로 인해 발생하는 것이다. 자연적인 노화의 경우나 외적 노화의 경우 모두 피부 내의 구조적 변화를 수반하게 되며 그 결과 피부는 건조해지고 피부 탄력성을 잃고 주름이 형성된다.All life is aging with age, and it goes through aging process in skin as well. Efforts to delay such aging have been constantly being carried out, and thus the question of what is the nature of aging and why aging is constantly being raised. Skin aging can be roughly divided into two types depending on the factors. One of them, intrinsic aging, is that the structure and physiological functions of the skin are constantly declining while aging, and the other, extrinsic aging, is caused by accumulated external stresses such as sunlight . Both natural aging and extrinsic aging involve structural changes in the skin, which results in dry skin, loss of skin elasticity and wrinkles.
우선 노화에 따른 피부의 구조적 변화를 좀 더 자세히 살펴보면, 피부의 구성성분인 표피, 진피 및 피하조직의 두께가 얇아진다. 또한, 피부의 탄력과 인장을 담당하는 진피 조직의 세포외 기질(extracellular matrix, ECM) 성분이 변화하게 된다. 세포 외 기질은 3차원의 지지체로서 무기염류, 영양분, 노폐물 등의 수용액과 거대 다당류 분자들이 포함되어 있다. 이는 세포를 둘러싼 공간에서 네트워크를 형성해 조직의 형태를 유지하고 지탱하며, 세포간의 신호전달 및 세포의 성장과 분화를 조절하는 중요한 역할을 한다. First, the structural changes of the skin due to aging are examined in more detail. The thickness of skin, dermis, and subcutaneous tissue, which are constituents of the skin, becomes thinner. In addition, the extracellular matrix (ECM) component of the dermis, which is responsible for elasticity and tensile of the skin, changes. The extracellular matrix is a three-dimensional support containing an aqueous solution of inorganic salts, nutrients, wastes and other large polysaccharide molecules. It forms a network in the space surrounding the cells to maintain and support the morphology of the tissue, and plays an important role in regulating cell signaling and cell growth and differentiation.
지금까지 모사된 ECM 성분은 대부분이 동물로부터 유래되었다. 하지만 동물유래 성분은 병원체 감염 등 안전성의 문제가 대두되면서 화장품에 사용하지 않는 추세이다.The ECM components that have been simulated so far are mostly derived from animals. However, animal-derived ingredients tend not to be used in cosmetics due to safety issues such as pathogen infection.
세포 외 기질 전체의 70~80%를 차지하는 주요 성분인 콜라겐은 길이가 긴 섬유구조 단백질 중의 하나로 피부강도와 탄성을 조절하므로 피부 노화, 즉 탄력감소나 주름형성 등과 밀접한 관련이 있다고 알려져 있다. 그러나 현재 사용되고 있는 대부분의 콜라겐이 동물유래 원료이고, 분자량이 약 30만Da 가량의 고분자이기 때문에 피부를 통한 전달에 있어 콜라겐 자체로의 흡수는 한계가 있다.Collagen, a major component of 70-80% of the entire extracellular matrix, is one of the longest fiber structure proteins that regulates skin strength and elasticity, and is known to be closely related to skin aging, such as elasticity and wrinkle formation. However, since most collagen currently used is an animal-derived raw material and has a molecular weight of about 300,000 Da, its absorption into collagen itself is limited in its transmission through the skin.
ECM 성분의 하나인 히알루론산(hyaluronic acid)은 피부 내 진피조직의 세포를 서로 결합시키고 영양분을 전달하는 역할을 하며 피부가 적절한 양의 수분을 유지할 수 있도록 한다. 하지만 히알루론산은 분자량이 수십만에서 수백만의 고분자이기 때문에 점도가 높아 화장품에 적용 시 사용량에 제한을 받으며, 피부에 직접 도포하여 피부를 투과하기가 매우 어렵다는 단점이 있다.One of the ECM components, hyaluronic acid, binds the cells of the dermis tissue in the skin and transports the nutrients, allowing the skin to maintain an adequate amount of moisture. However, since hyaluronic acid has a molecular weight of several hundred thousand to several millions, it is highly viscous and is limited in its application amount in cosmetics, and has a drawback in that it is very difficult to penetrate skin through direct application to the skin.
이에, 본 발명자들은 동물 유래 성분이 아닌 식물 유래 또는 합성을 통해 얻은 트리펩타이드, 저분자량 히알루론산, 미네랄, 비타민 등의 성분들을 세포 외 기질과 유사한 조성비로 만들고 피부 투과가 가능한 저분자 성분들을 이용하면 피부 세포의 재생을 촉진시킬 수 있음을 발견하고 본 발명을 완성하였다.Accordingly, the inventors of the present invention have found that when a low-molecular component capable of permeating skin is used to make components such as tripeptides, low molecular weight hyaluronic acid, minerals, and vitamins, which are not animal-derived components, Cell regeneration can be promoted and the present invention has been completed.
따라서, 본 발명의 목적은 세포외 기질을 모사하여 피부 세포의 재생을 촉진시키고 손상된 피부의 기능을 회복시키는 화장료 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a cosmetic composition which simulates extracellular matrix to promote regeneration of skin cells and restore the function of damaged skin.
상기한 목적을 달성하기 위하여, 본 발명은 글리신-프롤린-하이드록시프롤린(Gly-Pro-Hyp)으로 구성된 트리펩타이드, 저분자량 히알루론산, 미네랄 성분 및 비타민을 유효성분으로 함유하는 화장료 조성물을 제공한다.To achieve the above object, the present invention provides a cosmetic composition comprising a tripeptide composed of glycine-proline-hydroxyproline (Gly-Pro-Hyp), a low molecular weight hyaluronic acid, a mineral component and a vitamin as an active ingredient .
본 발명에 따라 세포외 기질을 모사한 화장료 조성물은 트리펩타이드, 저분자량 히알루론산, 미네랄 성분 및 비타민 등이 세포를 둘러싼 공간에서 네트워크를 형성해 조직의 형태를 유지하고 지탱하며, 세포간의 신호전달 및 세포의 성장과 분화를 조절함으로써 피부의 노화, 즉 탄력 감소나 주름형성을 억제하는 작용을 할 수 있으며, 피부 투과가 가능한 저분자의 성분들이 피부를 통한 전달을 효과적으로 할 수 있도록 하여 피부 세포 재생을 촉진시키고 손상된 피부의 기능을 회복시켜 준다.According to the present invention, a cosmetic composition prepared by simulating an extracellular matrix is characterized in that a tripeptide, a low molecular weight hyaluronic acid, a mineral component and a vitamin form a network in a space surrounding the cells to maintain and support the morphology of the tissue, Can control the growth and differentiation of the skin, thereby suppressing the aging of the skin, that is, reducing the elasticity and wrinkle formation. The low-molecular components capable of permeating the skin can effectively transmit through the skin to promote skin cell regeneration Restores the function of damaged skin.
도 1은 본 발명에 따른 조성물의 상처 회복능을 관찰한 현미경 사진이다.
도 2는 본 발명에 따른 조성물의 농도별 상처 회복능을 정량 분석한 그래프이다.
도 3은 본 발명에 따른 조성물의 피부 섬유아세포 증식 효과를 나타낸 그래프이다.
도 4는 본 발명에 따른 조성물의 피부 탄력 개선 효과를 나타낸 모아레 이미지이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a microscope photograph showing the wound repair ability of the composition according to the present invention. FIG.
FIG. 2 is a graph showing quantitative analysis of the wound healing ability according to the concentration of the composition according to the present invention. FIG.
3 is a graph showing the effect of the composition according to the present invention on the proliferation of dermal fibroblasts.
4 is a moire image showing the skin elasticity improving effect of the composition according to the present invention.
도 1에서 알 수 있듯이, DMEM 배지로만 처리한 대조군과 비교하여 상기 실시예 1을 사용한 실험군에서는 눈에 띄게 세포 손상 면적이 감소하였다. 또한, 도 2에서 알 수 있듯이, 실시예 1의 상대적인 상처 회복능이 대조군과 비교하여 우수함을 확인할 수 있었으며 농도에 비례하여 상처 회복능이 증가되었다.As can be seen from FIG. 1, the cell damage area was noticeably decreased in the experimental group using the above-mentioned Example 1 as compared with the control group treated only with the DMEM medium. In addition, as can be seen from FIG. 2, it was confirmed that the relative scar recovery ability of Example 1 was superior to that of the control group, and the scar repair ability was increased in proportion to the concentration.
따라서, 본 발명의 세포 외 기질을 모사한 화장료 조성물은 세포 재생을 촉진시킬 수 있으며 피부 손상을 빠르게 회복시킬 수 있다.Accordingly, the cosmetic composition of the present invention having the extracellular matrix mimicked can promote cell regeneration and restore skin damage quickly.
[시험예 2] 세포 증식 실험[Test Example 2] Cell proliferation experiment
40대의 사람 피부에서 분리한 섬유아세포를 96공에 1공 당 3x103개씩 파종하여 24시간 동안 M106배지에서 배양하였다. 대조군은 1% 소태아혈청(FBS), 양성대조군은 10% FBS을 사용하였고, 1% 실시예 1을 1% FBS 배지에 48시간, 72시간 동안 세포를 배양한 후, Roche사의 키트(Cell proliferation Elisa, BrdU)로 BrdU 분석(assay)를 실시하여 ELISA로 관찰하고, 그 결과를 도 3에 나타내었다.Fibroblasts isolated from skin of forty people were seeded in 96 wells at 3 × 10 3 per well and cultured in M106 medium for 24 hours. Cells were cultured in 1% FBS medium for 48 hours and 72 hours, and then cultured in a cell proliferation kit (Roche kit) (FBS) supplemented with 1% fetal bovine serum (FBS) as a control and 10% FBS as a positive control. Elisa, BrdU) and observed by ELISA. The results are shown in FIG.
도 3을 보면, 실시예 1이 48시간 후에는 양성대조군과 거의 유사한 증식 효과를 나타내었고, 72시간 후에는 양성대조군보다 월등히 높은 세포 증식 효과를 나타내는 것을 확인할 수 있었다. 따라서, 본 발명의 세포 외 기질을 모사한 화장료 조성물은 우수한 피부의 섬유아세포 증식 효과를 나타낼 수 있다.FIG. 3 shows that Example 1 showed almost the same proliferative effect as that of the positive control after 48 hours and significantly higher cell proliferation after 72 hours than the positive control. Therefore, the cosmetic composition mimicking the extracellular matrix of the present invention can exhibit excellent skin fibroblast proliferation effect.
[시험예 3] 피부 안전성 실험[Test Example 3] Skin safety test
40명의 건강한 성인(평균연령 39.6세, 피부병변 보유자 제외)을 대상으로 상기 실시예 1에서 제조된 조성물에 대한 알레르기성 및 원발성 접촉피부염을 일으키는지에 대해서 알아보기 위해서 정상인의 등에 추출물 20㎕를 IQ 챔버(chamber)에 고정시켜 첩포 검사를 시행하였다. 첩포는 24시간 동안 도포하고 첩포를 제거한 후 실험부위를 표시하여 30분, 24시간 후에 실험부위를 관찰하여 피부자극 여부를 CTFA 가이드라인(1981)과 Frosch & Kligman (1979)의 검사기준에서 수정된 검사기준인 하기 표 2에 제시된 기준에 의거하여 검사하였다.To examine whether allergic and primary contact dermatitis to the composition prepared in Example 1 was caused in 40 healthy adults (average age of 39.6 years, excluding skin lesion holders), 20 쨉 l of the extract of the normal person was applied to the IQ chamber and then fixed to a chamber to perform a patch test. After applying the patch for 24 hours and removing the patch, the experimental area was marked. After 30 minutes and 24 hours, the skin was stimulated by the CTFA guidelines (1981) and Frosch & Kligman (1979) The test was performed according to the criteria shown in Table 2 below.
등급 I (무자극 범위): 1 미만Class I (no stimulation range): less than 1
등급 II (경자극 범위): 3미만Class II (light stimulus range): less than 3
등급 III (중자극 범위): 5미만Grade III (moderate stimulus range): less than 5
등급 IV (강자극 범위): 5이상Class IV (Strong Stimulus Range): 5 or higher
상기와 같이 첩포 검사를 시행한 결과, 본 발명의 조성물은 모든 피검자에서 자극 점수가 0으로 판정되어 무자극으로 매우 안전한 화장료 조성물임을 알 수 있었다.As a result of the patch test, the composition of the present invention was found to be a safe cosmetic composition due to a non-stimulated stimulation score of 0 in all subjects.
[시험예 4] 인체피부에서의 탄력 효과 실험[Test Example 4] Elastic effect test on human skin
하기 표 3에 나타낸 조성으로 상기 실시예 1을 함유하는 크림 제형(실시예 2) 및 실시예 1을 함유하지 않는 크림 제형(비교예 1)을 통상의 제조 방법에 따라 제조하였다. A cream formulation (Example 2) containing the above Example 1 and a cream formulation (Comparative Example 1) containing no Example 1 were prepared according to the usual production method with the composition shown in the following Table 3.
(중량%)Example 2
(weight%)
(중량%)Comparative Example 1
(weight%)
제조한 실시예 2의 크림을 안면에 도포했을 때 피부 탄력성이 증가되는 효과를 측정하기 위해 35~45세 여성 22명을 대상으로 2개의 군으로 나누어 1군은 실시예 2를 아침, 저녁으로 1일 2회 도포하도록 하고, 다른 군은 비교예 1을 아침, 저녁으로 1일 2회 도포하도록 하였다. 그리고 3주, 6주 후에 피부 탄력을 측정할 수 있는 모아레 이미지를 이용하여 도포 전후의 안면 처짐각을 측정하였다. 모아레 이미지는 도 4에 나타내었고, 안면 처짐각의 측정 결과는 표 4에 나타내었다. 하기 표 4의 수치는 각군의 피험자의 평균값이다.In order to measure the effect of increasing the elasticity of the skin when the cream of Example 2 was applied on the face, 22 women aged 35 to 45 years were divided into two groups. In
도 4 및 표 4에 나타낸 바와 같이, 사용 6주 후에 비교예 1은 1.91%, 실시예 2는 5.17%의 안면 처짐각 감소를 나타내었다. 실시예 1이 안면 처짐각 개선에 보다 효과적으로 작용하는 것을 알 수 있었고, 이를 통해 본 발명의 조성물이 피부 탄력 증가 효과가 있음을 확인할 수 있었다.As shown in Fig. 4 and Table 4, after 6 weeks of use, Comparative Example 1 exhibited a reduction of facial deflection angle of 1.91% and Example 2 decreased 5.17%. It was found that Example 1 more effectively works to improve the facial deflection angle, and it is confirmed that the composition of the present invention has an effect of increasing skin elasticity.
[시험예 5] 피부톤 개선 실험[Test Example 5] Skin tone improvement experiment
피부 세포의 기능이 회복되고 재생이 촉진되면 불균일하던 피부톤이 균일하게 개선된다. 피부톤의 개선을 확인하기 위하여 35~45세 여성 22명을 대상으로 2개의 군으로 나누어 1군은 상기 실시예 2를, 다른 군은 비교예 1을 아침, 저녁으로 1일 2회 도포하도록 하였다. 그리고 3주, 6주 후 페이셜 스테이지(Facial Stage) DM-3(Moritex, Japan) 기기를 활용하여 피부톤 개선 정도를 평가하였다. 피부의 밝기에 대한 불균일도를 측정하여 그 결과를 하기 표 5에 나타내었다.When the function of the skin cells is restored and the regeneration is promoted, the uneven skin tone is uniformly improved. In order to confirm the improvement of skin tone, 22 women aged 35 to 45 years were divided into two groups. One group was applied to Example 2 and the other group was applied to Comparative Example 1 twice a day in the morning and evening. After 3 weeks and 6 weeks, facial stage DM-3 (Moritex, Japan) was used to evaluate the improvement of skin tone. The non-uniformity of skin brightness was measured and the results are shown in Table 5 below.
상기 표 5에 나타낸 결과, 피부톤의 불균일도는 6주 뒤 평가에서 실시예 2는 4.05% 감소된 반면, 비교예 1은 1.11% 감소되었다. 따라서, 본 발명에 따른 조성물이 피부톤을 균일하게 만드는데 효과가 있음을 확인하였다.As shown in Table 5, the unevenness of skin tone was reduced by 4.05% in Example 2, and by 1.11% in Comparative Example 1 in the evaluation after 6 weeks. Thus, it was confirmed that the composition according to the present invention is effective in uniformizing skin tone.
[제형예 1] 유연화장수[Formulation Example 1] Flexible longevity
상기 실시예 1을 함유하는 유연화장수 제형을 하기 표 6에 나타낸 조성으로 통상의 제조 방법에 따라 제조하였다.The formulated softening water containing the above Example 1 was prepared according to the usual production method with the composition shown in Table 6 below.
[제형예 2] 영양화장수[Formulation Example 2] Nutritional lotion
상기 실시예 1을 함유하는 영양화장수 제형을 하기 표 7에 나타낸 조성으로 통상의 제조 방법에 따라 제조하였다.A nutritional lotion formulation containing the above Example 1 was prepared according to a conventional preparation method with the composition shown in Table 7 below.
[제형예 3] 크림[Formulation Example 3] Cream
상기 실시예 1을 함유하는 크림 제형을 하기 표 8에 나타낸 조성으로 통상의 제조 방법에 따라 제조하였다.The cream formulations containing Example 1 were prepared according to the usual preparation methods with the compositions shown in Table 8 below.
Claims (8)
상기 저분자량 히알루론산은 분자량이 500~5000Da인 피부 세포 재생 촉진 및 손상 회복 촉진용 화장료 조성물.A tripeptide comprising glycine-proline-hydroxyproline (Gly-Pro-Hyp), a low molecular weight hyaluronic acid, a mineral component and a vitamin as active ingredients,
Wherein the low molecular weight hyaluronic acid has a molecular weight of 500 to 5000 Da.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20090116444 | 2009-11-30 | ||
KR1020090116444 | 2009-11-30 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100110217A Division KR20110060800A (en) | 2009-11-30 | 2010-11-08 | Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20170133297A true KR20170133297A (en) | 2017-12-05 |
KR101912329B1 KR101912329B1 (en) | 2018-10-26 |
Family
ID=44395497
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100110217A KR20110060800A (en) | 2009-11-30 | 2010-11-08 | Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell |
KR1020170157301A KR101912329B1 (en) | 2009-11-30 | 2017-11-23 | Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100110217A KR20110060800A (en) | 2009-11-30 | 2010-11-08 | Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell |
Country Status (2)
Country | Link |
---|---|
KR (2) | KR20110060800A (en) |
CN (1) | CN104887542B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102226810B1 (en) * | 2020-09-02 | 2021-03-15 | 주식회사 엘라스틱랩 | Composition for Promoting Biosynthesis of Elastin and Collagen in Connective tissue |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102064469B1 (en) * | 2012-04-30 | 2020-02-11 | (주)아모레퍼시픽 | Composition for promoting regeneration skin by laser |
KR102087136B1 (en) * | 2013-07-31 | 2020-03-10 | (주)아모레퍼시픽 | Skin external composition comprising bio water mimic fluid |
KR101693682B1 (en) * | 2014-03-21 | 2017-01-09 | 서울대학교병원 (분사무소) | Cosmetic composition containing ACQ |
KR102015903B1 (en) * | 2018-02-08 | 2019-08-28 | 주식회사 엘지생활건강 | Composition for optical clearing of skin comprising optical clearing agents |
WO2019156311A1 (en) * | 2018-02-08 | 2019-08-15 | 주식회사 엘지생활건강 | Composition comprising optical clearing agent for improving optical characteristic of skin |
WO2022169246A1 (en) * | 2021-02-02 | 2022-08-11 | 주식회사 엘지생활건강 | Cosmetic material composition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068297A1 (en) * | 2001-08-18 | 2003-04-10 | Deepak Jain | Composition and methods for skin rejuvenation and repair |
JP2007091637A (en) * | 2005-09-29 | 2007-04-12 | Fancl Corp | I-type collagen production promoting composition |
KR20080026924A (en) * | 2006-09-22 | 2008-03-26 | 주식회사 바이오랜드 | A composition comprising low molecular weight hyaluronic acid or the salt thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070207180A1 (en) * | 2006-03-02 | 2007-09-06 | Masao Tanihara | Synthetic polypeptide-containing bioapplicable material and film-forming material |
WO2008003321A2 (en) * | 2006-07-07 | 2008-01-10 | Novozymes Biopolymer A/S | Compositions with several hyaluronic acid fractions for cosmetic use |
-
2010
- 2010-11-08 KR KR1020100110217A patent/KR20110060800A/en active Application Filing
- 2010-11-30 CN CN201510204678.6A patent/CN104887542B/en active Active
-
2017
- 2017-11-23 KR KR1020170157301A patent/KR101912329B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068297A1 (en) * | 2001-08-18 | 2003-04-10 | Deepak Jain | Composition and methods for skin rejuvenation and repair |
JP2007091637A (en) * | 2005-09-29 | 2007-04-12 | Fancl Corp | I-type collagen production promoting composition |
KR20080026924A (en) * | 2006-09-22 | 2008-03-26 | 주식회사 바이오랜드 | A composition comprising low molecular weight hyaluronic acid or the salt thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102226810B1 (en) * | 2020-09-02 | 2021-03-15 | 주식회사 엘라스틱랩 | Composition for Promoting Biosynthesis of Elastin and Collagen in Connective tissue |
WO2022050479A1 (en) * | 2020-09-02 | 2022-03-10 | Elastic Lab Inc. | Composition for promoting biosynthesis of elastin and collagen in connective tissue |
Also Published As
Publication number | Publication date |
---|---|
CN104887542B (en) | 2021-07-20 |
CN104887542A (en) | 2015-09-09 |
KR101912329B1 (en) | 2018-10-26 |
KR20110060800A (en) | 2011-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101912329B1 (en) | Cosmetic composition biomimetically designed from extracellular matrix for recovering skin cell | |
CN105125476B (en) | A kind of anti-wrinkle essence and preparation method thereof | |
US8895515B2 (en) | Cosmetic composition for skin cell regeneration mimicking extracellular matrix | |
CN101791283B (en) | Cosmetic capable of eliminating striae gravidarum and scars | |
CN105168112A (en) | Anti-wrinkle toner and preparation method thereof | |
CN108379215B (en) | Lyophilized powder composition with skin whitening effect and cosmetic composition containing same | |
CN112294668B (en) | Hyaluronic acid injection | |
CN108618986A (en) | A kind of moisturizing anti-wrinkle Multifunctional mask liquid and preparation method thereof | |
KR102613845B1 (en) | Cosmetic composition for improvement of skin derived from natural products | |
KR20150120426A (en) | Cosmetic composition containing a brown alga extract, a yeast extract and ascorbic acid | |
CN114601748A (en) | Soothing and repairing composition and application thereof | |
CN111888314A (en) | Essence containing copper peptide and preparation method thereof | |
CN115317429A (en) | Composition containing recombinant collagen and having repairing and relieving effects, eye cream containing composition, preparation method and application | |
CN112043619B (en) | Peptide composition with repairing effect and preparation method and application thereof | |
CN110934772A (en) | Wrinkle-removing and anti-aging composition and application thereof in cosmetics | |
KR100955085B1 (en) | The preparation method of composition for moisturizing skin comprising extracts of pine needle | |
CN114903810A (en) | Anti-wrinkle composition containing peptide and application thereof | |
KR101154581B1 (en) | Cosmetic composition for skin moisturizing containing Criste Marine callus culture filtrate | |
CN113662876A (en) | Polypeptide beautifying essence and preparation method thereof | |
US11666518B2 (en) | Cosmetic anti-blemish composition, use of the composition and method for anti-blemish treatment | |
CN114146018B (en) | Moisturizing anti-aging Polypeptides composition, preparation method and face cream containing same | |
KR100955087B1 (en) | A composition comprising extracts of pine needle for moisturizing skin | |
KR100890068B1 (en) | Nourishing cream composition for keeping moisture of skin | |
CN117379336A (en) | Composition with skin repairing and enhancing effects, and preparation method and application thereof | |
CN116617129A (en) | Composition with skin repairing effect and skin care product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |